Search PDMR transactions

Notifier
Name of person with notification obligation
Sofia Heigis
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Sofia Heigis
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Oncopeptides AB SE0009414576 Acquisition 56,820 Quantity 4.40 SEK 26/08/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides AB SE0009414576 Acquisition 26/08/2025 NASDAQ STOCKHOLM AB 56,820 (Quantity) 4.40 SEK
Total: 56,820
<< Back